Abiopharma

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001193125-26-197535 <b>Size:</b> 1 MB

New Form 4/A - Processa Pharmaceuticals, Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0000897069-26-000979 <b>Size:</b> 6 KB

New Form DEF 14A - UroGen Pharma Ltd. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001437749-26-014237 <b>Size:</b> 3 MB

New Form POS AM - NEW ROYAL HOLDCO I INC. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001104659-26-053030 <b>Size:</b> 28 KB

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001918704-26-011629 <b>Size:</b> 566 KB

New Form ARS - ImageneBio, Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001140361-26-018276 <b>Size:</b> 2 MB

La Comisión Europea (CE) aprueba POHERDY® (pertuzumab) de Henlius y Organon, el primer biosimilar de PERJETA (pertuzumab) autorizado en Europa

New Form ARS - WaterBridge Infrastructure LLC <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001140361-26-018274 <b>Size:</b> 2 MB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001213900-26-050299 <b>Size:</b> 144 KB

New Form ARS - Septerna, Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001193125-26-197525 <b>Size:</b> 1 MB

New Form 4/A - Processa Pharmaceuticals, Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0000897069-26-000977 <b>Size:</b> 6 KB

New Form ARS - BEST BUY CO INC <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001140361-26-018275 <b>Size:</b> 971 KB

New Form DEFA14A - WaterBridge Infrastructure LLC <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001140361-26-018270 <b>Size:</b> 1 MB

New Form DEFA14A - BEST BUY CO INC <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001140361-26-018271 <b>Size:</b> 2 MB

New Form ARS - MAGNACHIP SEMICONDUCTOR Corp <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001193125-26-197507 <b>Size:</b> 1 MB